Minimal treatment usually OK for low-risk lymphocyte-predominant Hodgkin lymphoma

May 18, 2016

NEW YORK (Reuters Health) – Many children with low-risk lymphocyte-predominant Hodgkin lymphoma (LPHL) may be spared chemotherapy and radiotherapy after surgical resection alone, according to a new report from the Children’s Oncology Group.

“It is very interesting to see that 75% of the surgery-only patients were spared further treatment,” Dr. Burton E. Appel from Hackensack University Medical Center in New Jersey told Reuters Health by email.

Most children with LPHL are asymptomatic and have non-bulky, localized disease involving peripheral lymph nodes. There is no established standard of care for treatment of low-stage LPHL.

Visit JOURNALOFCLINICALPATHWAYS.COM to view the full article.